# Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.

> **NCT07114848** · PHASE4 · COMPLETED · sponsor: **Liaquat National Hospital & Medical College** · enrollment: 60 (actual)

## Conditions studied

- Ureteral Stent-Related Symptom
- Alpha Blocker
- Anticholinergics
- Ureter Calculi

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** solifenacin

## Key facts

- **NCT ID:** NCT07114848
- **Lead sponsor:** Liaquat National Hospital & Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-13
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07114848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07114848, "Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07114848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*